Evidence map›Paper›PMID 20638853›Full record

ArticleBioorganic & medicinal chemistry2010

Functional profiling of p53-binding sites in Hdm2 and Hdmx using a genetic selection system.

Shreya Datta, Megan E Bucks, Dipankar Koley, Pei Xin Lim, Sergey N Savinov

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shreya DattaDepartment of Chemistry, Purdue University, West Lafayette, IN 47907, USA.
Megan E Bucks
Dipankar Koley
Pei Xin Lim
Sergey N Savinov
Purdue University West Lafayette · US

Funding

Rescuing the anti-HIV activity of APOBEC3G with small-molecule chaperonsR21AI077482 · NIAID · PURDUE UNIVERSITY · PI SAVINOV, SERGEY N. · 2009 to 2010
$366k
NIAID NIH HHS 1R21AI077482-01NIAID NIH HHS R21 AI077482
6 · The paper itself

Abstract

Upregulation of structurally homologous oncoproteins Hdm2 and Hdmx has been linked to the depletion or inactivation of their common regulation target the tumor suppressor p53 protein leading to the progression of cancer. The restoration of the p53 function, rendered suppressed or dormant by these negative regulators, establishes, therefore, a unique opportunity for a targeted induction of apoptosis in cancers that retain wild-type p53. While several small molecules have been reported to rescue the tumor suppressor by antagonizing the Hdm2-p53 interaction, these agents displayed limited application scope by being ineffective in tumors enriched with active Hdmx. Here, we describe the use of a genetic selection system and encoded library of conformationally pre-organized peptides to perform functional profiling of each regulator revealing specific recognition features that guide the antagonism of Hdm2-p53 and Hdmx-p53 interactions. Structure-activity relationship analysis of the most effective leads identified functional and structural elements mediating selective recognition of the two structurally related regulators, while providing convenient starting points for further activity optimization.

Indexed as

Amino Acid SequenceBinding SitesCell Cycle ProteinsEscherichia coliGene ExpressionHumansModels, MolecularMutagenesisNuclear ProteinsPeptidesProtein BindingProtein Interaction MappingProto-Oncogene ProteinsProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53Cell Cycle ProteinsMDM4 protein, humanNuclear ProteinsPeptidesProto-Oncogene ProteinsProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53

Identifiers

PMID20638853
PMCPMC2922946
OpenAlexW2159213509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.